New imaging study aims to speed up myotonic dystrophy drug trials

NCT ID NCT07362875

First seen Jan 31, 2026 · Last updated May 14, 2026 · Updated 12 times

Summary

This study is developing a new MRI-based method to measure muscle changes in people with myotonic dystrophy, a condition that causes progressive muscle weakness. Researchers will scan the leg muscles of 75 adults (ages 18-65) with the disease and compare them to healthy volunteers. The goal is to create reliable biomarkers that can be used in future clinical trials to test potential treatments more effectively.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOTONIC DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Wake Forest University Health Sciences

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.